Top compounds associated with response to SIRPG


Feature Type Standardized
Nominal ANOVA
mRNA istradefylline CTRPv2 pan-cancer AAC -0.06 0.3
mRNA AZD8055 GDSC1000 pan-cancer AAC -0.037 0.3
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
mRNA HG-5-88-01 GDSC1000 pan-cancer AAC -0.051 0.3
mRNA BIRB 0796 CTRPv2 pan-cancer AAC -0.042 0.3
mRNA Methotrexate FIMM pan-cancer AAC -0.15 0.3
mRNA CP724714 GDSC1000 pan-cancer AAC 0.037 0.3
mRNA Dasatinib FIMM pan-cancer AAC -0.18 0.3
mRNA Z-LLNle-CHO GDSC1000 pan-cancer AAC -0.053 0.3
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.057 0.3
Download CSV